Table 3.

Selective antimicrobial peptides in clinical trial according to Refs. ⁵, ⁹², and ⁹³.

NAME	NUMBER OF AMINO ACIDS	DESCRIPTION	INTENDED USE	COMPANY	TRIAL PHASE
Omiganan (MBI-226, MX-226, CSL-001)	12	Synthetic analog of indolicidin	Topical antiseptic prevention of catheter infection, severe acne and rosacea	Migenix/BioWest therapeutics Cutanea Life Sciences	III/II
Pexiganan (MSI-78)	22	Synthetic analog of magainin 2	Topical antibiotic – diabetic ulcers	Macrochem	III
Iseganan (IB-367)	17	Protegrin 1 derivative	Prevention of oral mucositis	Ardea Biosciences	III
LTX-109	3	Peptidomimetic	Topical antibiotic	Lytic Biopharma	I/II
hLF1–11	11	Lactoferrin derivative	Prevention of bacteraemia and fungal infections	AM Pharma	I/II
OP-145	24	LL-37 derivative	Treatment of chronic middle ear infection	Octoplus	I/II